Isoquinolinone derivatives useful in the treatment of cancer
US9944641B2 · kind B2 · utility
0Cited by
0References
22Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 2, 2015 |
| Grant date | Apr 17, 2018 |
| Priority date | — |
| Expiry date | Sep 2, 2035 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to a compound of the following formula (I) or a pharmaceutically acceptable salt and/or solvate thereof, notably for use as a drug, notably in the treatment of cancer, as well as pharmaceutical compositions containing such a compound and processes to prepare such a compound.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.